For the Inventor, By the Inventor

Enter assignee name

H. Lundbeck A/s

USPTO Granted Patents = 513

% Expired Patents = 37.0

CIPO Patents = 22

EPO Patents = 161

Trademarks = 54

Forward Citations = 1,895

Loading Chart...

Loading Chart...

497 inventors (with patents filed for the assignee):

Jan Kehler (64 out of 65 patents)

Karsten Juhl (52 out of 54 patents)

Morten Langgård (46 out of 47 patents)

4. Jens Kristian Perregaard (44 out of 48 patents)

5. Benny Bang-Andersen (43 out of 44 patents)

6. Mauro Marigo (39 out of 39 patents)

7. Lars Kyhn Rasmussen (39 out of 43 patents)

8. Hans Petersen (34 out of 34 patents)

9. Mikkel Jessing (31 out of 33 patents)

10. Heidi Lopez De Diego (30 out of 33 patents)

11. John A Latham (28 out of 125 patents)

12. Ejner Knud Moltzen (28 out of 30 patents)

13. Kim Andersen (27 out of 27 patents)

14. Klaus Gjervig Jensen (24 out of 26 patents)

15. John Paul Kilburn (24 out of 29 patents)

Core Competencies:

Anti-CGRP Antibodies

Catecholamine Prodrugs

MAGL Inhibitors

Synucleinopathy Treatment

Alcohol Derivatives

LRRK2 Inhibitors

PACAP Antibodies

Epilepsy Treatments

Schizophrenia

Migraine Therapy

Neuropharmacology

Serotonin Modulators

513 patents: Sort by Forward Citations

1. 12747294 - ANTI-SORTILIN ANTIBODIES AND USE THEREOF (2026-09-29),

2. 12747291 - NUCLEIC ACIDS ENCODING HUMANIZED ANTI-PACAP ANTIBODIES (2026-09-29),

3. 12630614 - TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF (2026-05-19),

4. 12590142 - ANTIBODY PURIFICATION AND PURITY MONITORING (2026-03-31),

5. 12590106 - Spiromacrocyclic orexin 2 receptor agonists (2026-03-31),

6. 12545725 - Anti-PACAP antibodies, nucleic acids and methods of making thereof (2026-02-10),

7. 12508239 - Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures (2025-12-30),

8. 12479801 - Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5′:5,6]benzo[1,2-g]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol (2025-11-25),

9. 12428475 - Humanized anti-ACTH antibodies and use thereof (2025-09-30),

10. 12421303 - Agents, uses and methods for the treatment of synucleinopathy (2025-09-23),

11. 12421271 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2025-09-23),

12. 12398169 - Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2025-08-26),

13. 12398106 - Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease (2025-08-26),

14. 12391749 - Acute treatment and rapid treatment of headache using anti-CGRP antibodies (2025-08-19),

15. 12391650 - Catecholamine prodrugs for use in the treatment of Parkinson's disease (2025-08-19),

Company Overview

H. Lundbeck A/S is a global pharmaceutical company headquartered in Valby, Denmark, specializing in the development and commercialization of innovative treatments for neurological and psychiatric disorders. The company focuses on advanced therapeutic areas including anti-CGRP antibodies for migraine, catecholamine prodrugs, and MAGL inhibitors, among others. Lundbeck is committed to addressing complex conditions such as epilepsy and synucleinopathies, leveraging cutting-edge research to improve patient outcomes worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

513 Patents

#1 in Valby

#9 in Denmark

#1,895 in the World

H. Lundbeck A/s

Forward Citations = 1,895

497 inventors:

Jan Kehler (64 out of 65 patents)

Karsten Juhl (52 out of 54 patents)

Morten Langgård (46 out of 47 patents)

4. Jens Kristian Perregaard (44 out of 48 patents)

5. Benny Bang-Andersen (43 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: H. Lundbeck A/s. Retrieved from https://idiyas.com/company/h-lundbeck-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…